Additionally, it was observed that murine fetal SMO−/− HSCs retrovirally transduced with BCR-ABL1/GFP were less able to induce leukemia when injected into immunodeficient mice; disease latency was extended by more than three months in this group compared to the control group, and only 60% of recipients developed lethal disease [38]. Here, SMO is linked to leukemia.